| |||
| |||
CD200 Expression
antitumor immunity, cd200 expression, macrophage, XVIVO
“My experience working with XVIVO can be summed up in one word: Confidence. Confidence in the depth of scientific knowledge they contributed, this knowledge only enhanced the end product, was evident as a core competency from our initial discussions even before engaging them for the production, and inspired our team because they were collaborating with a partner who is as dedicated to the science of the story as they are.”
VP, Director of Production, JUICE Pharma Advertising
Active Cellular ImmunotherapyBiotechnology company Dendreon Corporation, has developed what is believed to be a method for getting around prostate ... Read More
The Inner Life of the CellHarvard University selected XVIVO to develop an animation that would take their cellular biology students on a journe ... Read More
Dengue Viral FusionDengue was created for Irene Bosch, Ph.D. at University of Massachusetts and Yorgo Modis, Ph.D. from Yale University. ... Read More
Zirus Antivirotics CondensedScientists at Zirus are working on a new technology platform to cure and manage viral infection through the developme ... Read More
Bacteriophage
RNAi Interference
Bio Chip